Overweight

The FDA approved the injectable GIP/GLP-1 dual incretin-based agonist tirzepatide for chronic weight management among adults with obesity, according to a press release.

CV deaths related to obesity increased by 200% across all race groups from 1999 to 2020, a statistic researchers said reflects the health consequences of the rising burden of obesity in the United States.

DANA POINT, Calif. — In this Healio video exclusive, Fatima Cody Stanford, MD, MPA, MPH, MBA, discusses considerations clinicians must make regarding women with obesity.

Adults with overweight or obesity in the U.S. have a one in 10 annual probability of achieving a 5% or greater weight loss, and the likelihood for weight loss increases with a higher initial BMI, according to study data.

A program to promote water drinking in elementary schools prevented increases in the prevalence of students with overweight, a study published in Pediatrics found.

BMI in the overweight range was not associated with an increased risk for all-cause mortality, highlighting the limitations of using BMI to predict mortality risk independent of other risk factors, researchers found.

Adolescents and young adults with overweight or obesity had poorer clinical outcomes than their normal-weight counterparts after receiving a pediatric regimen for treatment of acute lymphoblastic leukemia, study results showed.

BMI in the overweight range appeared independently associated with favorable outcomes among patients who underwent chemoradiotherapy for nonmetastatic head and neck cancer, according to study results published in JAMA Network Open.

Increased adalimumab dosage may improve disease severity in patients with overweight or obesity with moderate to severe hidradenitis suppurativa, according to a study.

Women with polycystic ovary syndrome are more likely to attempt to lose weight multiple times and perceive themselves as having overweight compared with women without PCOS, according to a study published in Obesity.